Next Wave: The Early Pipeline For Sepsis And Related Conditions
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
New approaches to sepsis therapy in early development aim to modulate immune and inflammatory response without the negative effects of generalized immunosuppression.